Pharma

Pharma

Fapon specializes in discovering and developing biologics for treating cancers, autoimmune diseases and other diseases where there are unmet medical needs. We have built several drug discovery platforms, including an antibody discovery platform based on the globally leading mammalian cell display technology, a platform for generating IL-10M fusion proteins, and a platform for developing multispecific antibodies using Fibody and nanobodies. We have also built a differentiated pipeline of leading drug candidates.

Fapon Biopharma

Fapon Biopharma, founded in 2015, has world-leading antibody discovery and bispecific antibody platforms to support over 20 projects in the pipeline that target different steps of the cancer-immunity cycle. It is committed to enabling more reliable and affordable biologics.

Fapon Halobio

Fapon Halobio, cofounded with a world expert in circular RNA, is an innovative RNA therapy company focusing on technology platforms and early-stage R&D. With a roadmap to tackle technological bottlenecks, it aims to advance technologies and stimulate the industry.